GE Junction Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer (NCT00165464) | Dana-Farber Cancer Institute | 2001-08-01 |
Track GE Junction Cancer automatically
Every clearance here is in the API, with alerts when new ones post.